| clinical trial | Q30612 |
| P3098 | ClinicalTrials.gov ID | NCT04481750 |
| P6099 | clinical trial phase | phase I clinical trial | Q5452194 |
| P17 | country | Japan | Q17 |
| P582 | end time | 2018-08-03 | |
| P4135 | maximum age | 45 | |
| P2899 | minimum age | 20 | |
| P1132 | number of participants | 74 | |
| P4844 | research intervention | edaravone | Q335099 |
| P8005 | research subject recruitment status | completed | Q76651189 |
| P580 | start time | 2018-03-20 | |
| P8363 | study type | interventional study | Q78089383 |
| P1476 | title | Phase I Study of Oral Edaravone in Healthy Adult Males (Single- and Multiple-dose Study) |
Search more.